Home » Trials » SLCTR/2024/022 » Protocols
Date
2025-03-11
Protocol
Protocol changed
Item Changed
Inclusion criteria
Previous Version
• Males and females age >=18 years • Current hospitalization or recently discharged with the primary diagnosis of heart failure • Heart failure signs and symptoms at the time of hospital admission • Imaging evidence of mildly reduced or preserved left ventricular ejection fraction (EF) (40% or higher) • Elevated N-terminal pro B-type natriuretic peptide (NTproBNP) >=1000 pg/mL or B-type natriuretic peptide (BNP) >=250 pg/mL for patients without atrial fibrillation (AF); or elevated NTproBNP >=2000 pg/mL or BNP >=500 pg/mL for patients with AF
Next Version
• Males and females age >=18 years • Current hospitalization or recently discharged with the primary diagnosis of heart failure • Heart failure signs and symptoms at the time of hospital admission • Imaging evidence of mildly reduced or preserved left ventricular ejection fraction (EF) (40% or higher) • Elevated N-terminal pro B-type natriuretic peptide (NTproBNP) >=500 pg/mL or B-type natriuretic peptide (BNP) >=125 pg/mL for patients without atrial fibrillation (AF); or elevated NTproBNP >=1500 pg/mL or BNP >=375 pg/mL for patients with AF